Denali’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Denali Therapeutics discovers, develops and commercializes therapies for the treatment of neurodegenerative diseases. Read more

Ryan Watts's photo - President & CEO of Denali

President & CEO

Ryan Watts

CEO Approval Rating

100/100

Founded:

2013

Status:

PublicNASDAQDNLI

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Alector is Denali's top competitor. Alector is a Public company that was founded in South San Francisco, California in 2013. Alector operates in the Biotechnology industry. Alector has 26 fewer employees vs. Denali.

Cortexyme has been one of Denali's top competitors. Cortexyme is headquartered in South San Francisco, California, and was founded in 2012. Cortexyme is in the Biotechnology field. Cortexyme generates NaN% the revenue of Denali.

Alzheon is perceived as one of Denali's biggest rivals. Alzheon was founded in 2013 in Framingham, Massachusetts. Alzheon competes in the Biotechnology field. Alzheon generates $20.2M less revenue than Denali.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Verge Genomics a competitor of Denali?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$27.7M

Denali's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 22.7M. Over the last four quarters, Denali's revenue has decreased by 57%. Specifically, in Q2 2020's revenue was $5.8M; in Q1 2020, it was $3.6M; in Q4 2019, it was $13.1M; in Q3 2019, Denali's revenue was $13.6M.

Acquisitions

No recent acquisitions found related to Denali

Denali Funding History

$217M$347M$597M

Since Denali was founded in 2013, it has participated in 3 rounds of funding. In total Denali has raised $597.0M. Denali's last funding round was on Dec 2017 for a total of $250.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Dec 2017
$250M
-
Series B
Aug 2016
$130M
Series A
May 2015
$217M

Total Funding: $597M

Since Denali was founded in 2013, it has participated in 3 rounds of funding. In total Denali has raised $597.0M. Denali's last funding round was on Dec 2017 for a total of $250.0M

Investments

No recent investments found related to Denali

Denali News

August 18, 2020Zolmax News

Denali Therapeutics Inc (NASDAQ:DNLI) Expected to Announce Quarterly Sales of $287.35 Million

Analysts expect Denali Therapeutics Inc (NASDAQ:DNLI) to post sales of $287.35 million for the curren... See more »
August 7, 2020BioSpace

Denali Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of ... See more »
August 7, 2020Zacks

Crypto.com Enables 'Soft Staking' for Dai (DAI) Stablecoin

Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of 8.20% and 57.60%, respect... See more »
August 7, 2020Zacks

Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates

Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of 8.20% and 57.60%, respect... See more »
August 6, 202024/7 Wall St.

Denali Therapeutics Takes Next Big Step in Treating Parkinson's

Denali Therapeutics announced early Thursday that it would be progressing its Parkinson's treatment i... See more »

Denali Press Releases

February 27, 2020centralcharts

Denali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI... See more »
February 20, 2020Newswise

MD Anderson announces strategic collaboration with Denali Therapeutics to research and develop targeted therapies for neurodegenerative diseases

MD Anderson announces a strategic research collaboration with Denali Therapeutics to develop new targ... See more »
November 6, 2019centralcharts

Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI... See more »
September 4, 2019GlobeNewswire

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson's Disease and Launch of Its Engage Parkinson's Website

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNL... See more »
June 11, 2019GlobalNewswire

Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs

SOUTH SAN FRANCISCO, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI... See more »
May 8, 2019GlobeNewswire

Denali Therapeutics Reports First Quarter 2019 Financial Results

SOUTH SAN FRANCISCO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI)... See more »
March 12, 2019GlobeNewswire

Denali Therapeutics Reports Full Year 2018 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNL... See more »

Headquarters

161 Oyster Point Blvd.

South San Francisco, California94080

650-866-8548

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Denali Therapeutics discovers, develops and commercializes therapies for the treatment of neurodegenerative diseases. Denali was founded in 2013. Denali's headquarters is located in South San Francisco, California, USA 94080. It has raised 597.0M in 3...

CEO

Denali's President & CEO, Ryan Watts, currently has an approval rating of 100%. Denali's primary competitors are Alector, Cortexyme & Alzheon.

Website

denalitherapeutics.com

Frequently Asked Questions about Denali

  1. When was Denali founded?

    Denali was founded in 2013
  2. Who is Denali's CEO?

    Denali's CEO is Ryan Watts
  3. How much revenue does Denali generate?

    Denali generates $27.7M in revenue
  4. How much funding does Denali have?

    Denali has historically raised $597M in funding
  1. Where is Denali's headquarters?

    Denali's headquarters is in South San Francisco California, USA
  2. How many employees does Denali have?

    Denali has 179 employees
  3. What sector does Denali operate in?

    Denali is in Pharmaceuticals, Biotechnology
  4. Who are Denali's competitors?

    Denali's top competitors are Alector, Cortexyme, Alzheon